Prot# MCC-135-A02: Phase IIa, Rndmzd, Dbl-Bld, Plcbo-Controlled Clinical Trial to Examine Safety & Efficacy of Intravenous MCC-135 as an Adjunct to Standard Therapy w/ Primary PCI in Patients Diagnosed as Having an ST Elevation Acute Mycardial Infarction

Project: Research project

Project Details

Effective start/end date7/28/049/15/06


  • Ingenix Pharmaceutical Services, Inc. (MCC-135-A02)
  • Mitsubishi Pharma America, Inc. (MCC-135-A02)